What the policy actually says
Meta's public Advertising Standards (available at transparency.meta.com) cover dozens of restricted product categories. The ones peptide brands typically encounter:
- Unsafe substances— Meta's definition includes anabolic steroids, performance- enhancing substances, and supplements with banned ingredients. Some peptides fall in or near this definition depending on positioning.
- Online pharmacies + prescription drugs — ads for prescription drugs or services that prescribe prescription drugs require Meta written permission. Compounded GLP-1 brands are technically a subset of this.
- Drugs + drug-related products— any ad implying recreational drug use, even if the product itself isn't recreational, is restricted.
- Weight loss products + services — a separate restricted category with its own subrules (no before/after photos, no specific weight-loss numbers without disclosure, no targeting under 18).
- Cosmetic medical procedures + body modification — relevant for peptide brands positioning around skin, anti-aging, or body composition.
How Meta enforces the policy
Three independent layers, applied sequentially:
Layer 1: Automated ad copy review (seconds)
When you submit an ad, Meta's NLP models scan the text against banned-phrase lists. The models are trained on millions of historical policy violations, so they catch subtle language that human reviewers might miss. Common triggers in the peptide category: dosing language (mg/ml + frequency patterns), efficacy claims (cure, treat, reverse, guaranteed), prescription drug comparisons.
Layer 2: Automated creative review (seconds-minutes)
Image and video assets get scanned by Meta's computer vision models. Restricted-product flags for peptide brands: syringes/needles, transformation imagery (before/after), people visibly administering substances, anything that could imply recreational drug use.
Layer 3: Landing page review (hours-days, ongoing)
Meta's crawlers visit the landing page your ad links to. They check for: missing age-gates (required for adult products), missing legal disclosures, copy that implies different positioning than the ad, and various structural elements that signal a legitimate vs spammy operation.
Crucially, Layer 3 isn't a one-time check. Meta re-crawls landing pages periodically — your ad can pass review on day 1 and get flagged on day 30 if you update the landing page or if Meta's policies tighten.
Why advertisers keep running into the policy
Most violations are unintentional
The vast majority of peptide-brand policy violations aren't deliberate evasion. They're generalist marketers using language patterns that work in other categories (“lose 15 lbs,” “clinically proven,” “doctor recommended”) without realizing those exact phrases are in Meta's banned lists for restricted products.
The policy is asymmetric
Meta gives advertisers in unrestricted categories (fashion, SaaS, standard e-commerce) considerable latitude for marketing language. Brands in restricted categories get held to a much stricter standard. Operators who've advertised in other categories often don't realize the standard shifted.
Enforcement scales with spend
Small ad accounts ($50-$200/day) often fly under the radar of Meta's manual policy reviewers. Once an account scales past $500-$1,000/day in spend, it crosses thresholds that trigger manual human review — which catches edge cases that automated review missed.
This is why many peptide operators report “the account worked fine for months, then got disabled when we scaled.” The account didn't change; the level of scrutiny did.
Account disable vs ad rejection — different consequences
Ad rejection is annoying but recoverable. One ad gets disapproved, you revise it, resubmit as a new ad. The account itself is fine.
Account disable is much worse. The entire ad account gets shut down, all ads stop running, pending spend is frozen for 30-90 days, and the appeal process succeeds in only 10-15% of cases. Most disabled accounts stay disabled.
What pushes an account from rejections to disable: pattern recognition (5-10+ rejections in a row triggers account-level review), landing page violations (carry more weight than ad-level violations), domain reputation history, and payment method history.
What the policy doesn't cover
Despite the strict policies, several peptide-adjacent categories aren't explicitly restricted:
- Topical skincare peptides (copper peptides in cosmetic products)
- Oral peptide supplements positioned as standard dietary supplements (not weight loss, not therapeutic)
- Research equipment + laboratory consumables (as long as ads don't imply human consumption)
- Educational content about peptides (medical education, research overviews — without selling specific products)
Brands operating cleanly in these adjacent spaces often face much lighter policy enforcement than brands selling peptides for human use.
For brands operating in the restricted lane
If you're a peptide brand operating in the restricted-product lane (most research peptide brands, most therapeutic-positioning brands), the policy is going to apply to you. The question is how to operate within it without burning through ad accounts.
That's what we do — see our Meta ads agency service.